Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in Net LoansChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Shares Issued (2019 - 2025)

Abvc Biopharma (ABVC) has disclosed Shares Issued for 8 consecutive years, with $528183.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 151.52% year-over-year to $528183.0, compared with a TTM value of $3.3 million through Dec 2025, up 248.84%, and an annual FY2025 reading of $3.3 million, up 248.84% over the prior year.
  • Shares Issued was $528183.0 for Q4 2025 at Abvc Biopharma, down from $2.6 million in the prior quarter.
  • Across five years, Shares Issued topped out at $4.2 million in Q4 2021 and bottomed at -$263031.0 in Q2 2024.
  • Average Shares Issued over 5 years is $1.1 million, with a median of $411667.0 recorded in 2025.
  • The sharpest move saw Shares Issued surged 1399.34% in 2021, then plummeted 105.97% in 2022.
  • Year by year, Shares Issued stood at $4.2 million in 2021, then tumbled by 105.97% to -$253500.0 in 2022, then soared by 372.94% to $691900.0 in 2023, then tumbled by 69.65% to $210000.0 in 2024, then surged by 151.52% to $528183.0 in 2025.
  • Business Quant data shows Shares Issued for ABVC at $528183.0 in Q4 2025, $2.6 million in Q3 2025, and -$241667.0 in Q2 2025.